TTOO T2 Biosystems, Inc.

NAS · US · Healthcare · Diagnostics & Research · investors.t2biosystems.com

0.0002USD-80.00%Mkt Cap: 5609 $P/E: —21d ago

T2 Biosystems, Inc. engages in the development and commercialization of medical diagnostic products for critical unmet needs in the healthcare. Its products include T2Dx instrument, T2Candida panel, and T2Bacteria panel.…

Industry Peers

Diagnostics & Research

Screen all

TMO

Thermo Fisher Scientific Inc.

Agilent Technologies, Inc.

IDEXX Laboratories, Inc.

$39.97BUSDP/E 35.6

MTD

Mettler-Toledo International Inc.

$30.73BUSDP/E 34.6

Labcorp Holdings Inc.

$25.30BUSDP/E 25.8

DGX

Quest Diagnostics Incorporated

$25.06BUSDP/E 24.1

Guardant Health, Inc.

Medpace Holdings, Inc.

$16.87BUSDP/E 35.5

ERF

Eurofins Scientific SE

$14.23BUSDP/E 26.6

CRL

Charles River Laboratories International, Inc.

$14.34BUSD

ICLR

ICON Public Limited Company

Key Statistics

Company

Market Cap5.61K USD

Enterprise Value16.87M USD

Revenue (TTM)7.68M USD

Gross Profit-8.17M USD

Net Income (TTM)-50.08M USD

Revenue/Share0.73 USD

Last Price0.0002 USD

Fiscal Year EndDec 2023

MR QuarterSep 2024

Employees113

CountryUS

SectorHealthcare

IndustryDiagnostics & Research

ISINUS89853L2034

Valuation

P/E (Trailing)—

P/E (Forward)-0.00

PEG—

EV/EBITDA-0.41

EV/Revenue2.20

P/S0.00

P/B-0.00

EPS (TTM)-0.06

EPS (Forward)-1.19

52W Range

0.00010% of range0.0800

52W High0.0800 USD

52W Low0.0001 USD

Profitability

Gross Margin-113.58%

Oper. Margin-511.89%

EBITDA Margin0.00%

Profit Margin-696.19%

ROE178.62%

ROA-143.91%

Growth

Revenue Growth34.90%

Earnings Growth—

Cash Flow & Leverage

Operating CF-48.14M USD

CapEx (TTM)192.00K USD

FCF Margin-343.45%

FCF Yield-470081.58%

Net Debt16.86M USD

Net Debt/EBITDA-0.41

Balance Sheet

Debt/Equity-1.77

Current Ratio0.40

Quick Ratio0.17

Book Value/Sh-0.62 USD

Cash/Share0.10 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 USD

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio—

Ex-Div Date—

Pay Date—

Splits

Last Split1:100

Split DateOct 13, 2023

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.28.05M

Float13.02M

Insiders0.03%

Institutions0.00%

Short Interest

Short Ratio0.7d

Short % Float4.87%

Short % Out.3.02%

Shares Short846.14K

Short (prev mo.)942.49K

Technical

SMA 500.0007 (-71.3%)

SMA 2000.0014 (-85.2%)

Beta8.18

S&P 52W Chg16.45%

Avg Vol (30d)7.74K

Avg Vol (10d)4.73K

Technical Indicators

RSI (14)34.3

MACD0.0000

MACD Signal0.0001

MACD Hist.-0.0000

BB Upper0.0014 USD

BB Middle0.0008 USD

BB Lower0.0003 USD

BB Width132.53%

ATR (14)0.0007 USD

Vol Ratio (20d)5.76x